Felipe A. Lisboa, MD, is an Investigator at the Surgical Critical Care Initiative (SC2I) and Research Assistant Professor at the USU Department of Surgery with more than ten years of experience in both basic and clinical research. He currently serves as the SC2i Associate Director of Clinical Research and SC2i USU/WR Biorepository Director. After graduating from medical school, Dr. Lisboa has also completed one year of postgraduate medical education, training in general surgery at the Military Hospital of Minas Gerais (HPM), Belo Horizonte, Brazil. Next, Dr. Lisboa pursued training in basic research and completed seven years of postdoctoral fellowships studying molecular immunology and molecular biology at both the NHLBI/NIH and USU.

At SC2i, Dr. Lisboa has continually worked on the investigation of inflammatory response mechanisms associated with wound healing, critical care and surgical research developing and implementing clinical study protocols, expanding the SC2i USU/WR Biorepository inventory, and exploring ways of utilizing precision medicine research and machine learning methods to develop clinical decision support tools aimed at improving the treatment of surgical military and civilian patients. To fulfill these goals, his research is currently dedicated to the investigation of methods and mechanisms of precision medicine, surgical critical care, angiogenesis, inflammatory response, immunology, molecular biology, and the utilization of machine learning in clinical research. More recently, Dr. Lisboa and his colleagues at SC2i are focusing on the study of multiomics-related mechanisms, involving genomics, proteomics and metabolomics associated with the risk, development and recovery of surgical treatment complications such as wound failure, local infection, sepsis, pneumonia, ARDS, AKI, and VTE.